Harmonic shows strong topline growth and market penetration, driven by innovation and strategic partnerships. See why I rate ...

Third Harmonic Bio is going to shut down, should shareholders accept a plan by directors to liquidate the San Francisco ...

We recently published a list of Top 8 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at where Harmonic Inc. (NASDAQ:HLIT) stands against other top AI news ...

Investors considering a purchase of Harmonic, Inc. (Symbol: HLIT) stock, but tentative about paying the going market price of $9.60/share, might benefit from considering selling puts among the ...

SAN JOSE, Calif., April 14, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced it will release its first quarter 2025 financial results after the market close on Monday, April 28, 2025.

Shares of Third Harmonic Bio, Inc. (THRD) drew investor attention on Monday after the company announced that its board of ...

Third Harmonic Bio has abandoned plans to take its chronic spontaneous urticaria (CSU) drug into phase 2, instead preparing ...

The Atlas-backed company plans to liquidate its assets, including an experimental drug for chronic spontaneous urticaria it ...

Third Harmonic Bio Inc (NASDAQ:THRD) shares are soaring on Monday after the company announced a plan of liquidation and dissolution.

Board of Directors has approved plan to liquidate and intends to seek stockholder approval for dissolution of the Company at the Annual Meeting ...

In this article, we are going to take a look at where Harmonic Inc. (NASDAQ:HLIT) stands against other top AI news updates investors should not miss. The global AI industry is growing at a rapid ...

Harmonic (NASDAQ: HLIT) today announced it will release its first quarter 2025 financial results after the market close on ...